regulatory

Government spending bill tweak means 3 more NDAs will become BLAs, FDA says
Government spending bill tweak means 3 more NDAs will become BLAs, FDA says
Endpoints
legislation
regulatory
biologics
NDAs
BLAs
FDA
Flag link:
Washington took a decade to approve an obscure drug-pricing bill. That’s a bad omen for more ambitious reforms
Washington took a decade to approve an obscure drug-pricing bill. That’s a bad omen for more ambitious reforms
Stat
drug pricing
regulatory
legislation
Donald Trump
Flag link:
FiercePharmaPolitics—Pharma price hikes rang in 2020, but how will Washington respond?
FiercePharmaPolitics—Pharma price hikes rang in 2020, but how will Washington respond?
Fierce Pharma
drug pricing
legislation
regulatory
2020 Presidential election
Flag link:
Annual Ritual Of Drug Price Increases To Get More Political Scrutiny In 2020
Annual Ritual Of Drug Price Increases To Get More Political Scrutiny In 2020
Forbes
drug pricing
2020 Presidential election
regulatory
Flag link:
Medtech Trends to Watch in 2020
Medtech Trends to Watch in 2020
Medical Devices and Diagnostics Industry
devices
digital health
5G
wearables
data
robotics
personalized medicine
IVDs
homecare
sterlization
startups
regulatory
Flag link:
PhRMA Challenges Oregon Drug Pricing Transparency Laws
PhRMA Challenges Oregon Drug Pricing Transparency Laws
FDA Law Blog
PhRMA
Oregon
regulatory
drug pricing
transparency
Flag link:
Pharma fury as Trump’s team reneges on biologic patent rules in trade talks
Pharma fury as Trump’s team reneges on biologic patent rules in trade talks
Pharmaforum
trade
biologics
drug pricing
regulatory
Canada
Mexico
China
Flag link:
How The House Prescription Drug Plan Would Try To Lower Drug Prices
How The House Prescription Drug Plan Would Try To Lower Drug Prices
NPR
drug pricing
legislation
regulatory
Lower Drug Costs Now Act of 2019
Flag link:
Is Congress Poised to Deal a Significant Blow to Hatch-Waxman and the Generic Drug Industry?
Is Congress Poised to Deal a Significant Blow to Hatch-Waxman and the Generic Drug Industry?
FDA Law Blog
FDA
drug pricing
Hatch Waxman Act
legislation
regulatory
generics
Flag link:
In a win for industry, Trump administration issues scathing review of Pelosi drug pricing bill
In a win for industry, Trump administration issues scathing review of Pelosi drug pricing bill
Endpoints
drug pricing
Donald Trump
Nancy Pelosi
legislation
regulatory
Flag link:
FDA Commissioner nominee Hahn promises to put science above politics
FDA Commissioner nominee Hahn promises to put science above politics
Fierce Pharma
FDA
Stephen Hahn
political
regulatory
Flag link:
Biopharma Execs Remain Optimistic Despite Political Headwinds
Biopharma Execs Remain Optimistic Despite Political Headwinds
Xconomy
drug pricing
regulatory
Brexit
political
Flag link:
Drug cost legislation gets a push from White House
Drug cost legislation gets a push from White House
AP
drug pricing
regulatory
legislation
Flag link:
A new bill would let more doctors prescribe addiction treatments without waiting for insurers’ permission
A new bill would let more doctors prescribe addiction treatments without waiting for insurers’ permission
Stat
regulatory
legislation
drug addiction
Flag link:
FDA Seeks to Pull 4 NDAs After Companies Failed to Submit Annual Reports
FDA Seeks to Pull 4 NDAs After Companies Failed to Submit Annual Reports
RAPS.org
FDA
regulatory
annual reports
NDAs
Flag link:
Yet another poll finds Americans favor drug pricing action. Will lawmakers respond?
Yet another poll finds Americans favor drug pricing action. Will lawmakers respond?
Fierce Pharma
drug pricing
legislation
regulatory
Flag link:
Durbin Pushes for Senate Vote on Bill to Include Drug Prices in Ads
Durbin Pushes for Senate Vote on Bill to Include Drug Prices in Ads
RAPS.org
drug pricing
drug ads
DTC ads
legislation
regulatory
Flag link:
The Pelosi Plan and “Me Too” Drugs
The Pelosi Plan and “Me Too” Drugs
BIOTechNow
regulatory
legistlation
me-too drugs
Nancy Pelosi
Flag link:
House unanimously clears PBM transparency bills
House unanimously clears PBM transparency bills
Politico
PBMs
transparency
drug pricing
regulatory
legislation
Flag link:
Pelosi bill goes to full House, anti-importation campaign backed by PhRMA
Pelosi bill goes to full House, anti-importation campaign backed by PhRMA
Fierce Pharma
regulatory
legislation
Nancy Pelosi
drug pricing
PhRMA
Flag link:

Pages